未登录

G

Giovanni Micera

University of Sassari

H指数:53

被引数:8,325

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations

INORGANIC CHEMISTRY

IF4.7

2017-10-0645

PREAI

Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug

DALTON TRANSACTIONS

IF3.3

2017-01-0175

PREAI

Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 3. Antioxidant properties and radical production capability

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2016-08-0127

PREAI

Nonoxido VIV Complexes: Prediction of the EPR Spectrum and Electronic Structure of Simple Coordination Compounds and Amavadin

INORGANIC CHEMISTRY

IF4.7

2016-07-1138

PREAI

Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2015-12-0130

PREAI

Speciation of the Potential Antitumor Agent Vanadocene Dichloride in the Blood Plasma and Model Systems

INORGANIC CHEMISTRY

IF4.7

2015-08-1732

PREAI

Characterization and biotransformation in the plasma and red blood cells of VIVO2+ complexes formed by ceftriaxone

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2015-06-0118

PREAI

Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 1. Coordination modes and geometry in solution and at the physiological pH

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2014-11-0143

PREAI

Interaction of Antidiabetic Vanadium Compounds with Hemoglobin and Red Blood Cells and Their Distribution between Plasma and Erythrocytes

INORGANIC CHEMISTRY

IF4.7

2014-01-1792

PREAI

Structural and redox requirements for the action of anti-diabetic vanadium compounds

DALTON TRANSACTIONS

IF3.3

2014-01-0183

PREAI

Interaction of Insulin-Enhancing Vanadium Compounds with Human Serum holo-Transferrin

INORGANIC CHEMISTRY

IF4.7

2013-10-0395

PREAI

Formation of New Non-oxido Vanadium(IV) Species in Aqueous Solution and in the Solid State by Tridentate (O, N, O) Ligands and Rationalization of Their EPR Behavior

INORGANIC CHEMISTRY

IF4.7

2013-07-0254

PREAI

VIVO Versus VIV Complex Formation by Tridentate (O, Narom, O) Ligands: Prediction of Geometry, EPR 51V Hyperfine Coupling Constants, and UV-Vis Spectra

INORGANIC CHEMISTRY

IF4.7

2013-04-1243

PREAI

Formation in aqueous solution of a non-oxido VIV complex with VN6 coordination. Potentiometric, ESI-MS, spectroscopic and computational characterization

DALTON TRANSACTIONS

IF3.3

2013-01-0124

PREAI

Transport of the anti-diabetic VO2+ complexes formed by pyrone derivatives in the blood serum

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2012-10-0172

PREAI

Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin

DALTON TRANSACTIONS

IF3.3

2012-01-0158

PREAI

VO2+ Complexation by Bioligands Showing Keto-Enol Tautomerism: A Potentiometric, Spectroscopic, and Computational Study

INORGANIC CHEMISTRY

IF4.7

2011-09-0851

PREAI

Impact of histidine residue on chelating ability of 2′-deoxyriboadenosine

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2011-09-013

PREAI

Synthesis and characterization of the chemical properties of new classes of NO donors as potential dopamine releasers in the treatment of Parkinson's disease

CURRENT OPINION IN BIOTECHNOLOGY

IF7

2011-09-010

PREAI

Interaction of VO2+ Ion and Some Insulin-Enhancing Compounds with Immunoglobulin G

INORGANIC CHEMISTRY

IF4.7

2011-03-2471

PREAI